EQPT vs IOVA
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
EQPT · EquipmentShare.com$14.68 ▲ 7.39%
IOVA · Iovance Biotherapeutics$8.04 ▲ 3.88%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- EQPT -54.9%
- IOVA +204.5%
Head to head
| Metric | EQPT | IOVA |
|---|---|---|
| Price | $14.68 | $8.04 |
| Change today | ▲ 7.39% | ▲ 3.88% |
| Market cap | $3.72B | $3.72B |
| Return, 3 months | -25.7% | +25.6% |
| Return, year to date | – | +194.5% |
| Return, 1 year | – | +249.6% |
| P/E (TTM) | 148.3 | -16.4 |
| P/B | 3.1 | 4.6 |
| P/E percentile vs own 5y | 30th | 3rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +26.3% | +65.7% |
| Net profit growth (YoY) | +18.8% | +57.6% |
| Gross margin | 29.2% | 48.4% |
| Operating margin | 6.8% | -91.1% |
| Net margin | 0.5% | -89.1% |
| Return on equity | 4.0% | -40.7% |
| Analyst target vs. price | +80.0% | +95.9% |
| Analyst buy share | 71% | 100% |
| RSI (14) | 42 | 33 |
| 30-day volatility | 95.5% | 172.4% |
| Max drawdown, 1 year | -60.8% | -47.9% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- IOVA is the largest of the group by market value.
- IOVA carries the lowest trailing P/E.
- IOVA is growing revenue fastest.
- EQPT keeps the most profit per dollar of sales.
- EQPT has been the calmest stock over the last 30 days.